Adel Inc.
Songpa-gu, Seoul, KR· latest recorded location
ADEL INC. is named on 1 US grants and 5 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 1
- Published applications
- 5
- Inventors
- 5
- Granted in 2026 so far
- 0
- Most recent grant
- 11 May 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 1 | 1 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Technology areas
Share of 6 documents
Recent patents
- Fusion comprising anti-tau antibody and peptide and use thereof16 Jul 2026US 2026/0201024 A1
- Animal model for diseases associated with absence or reduction of social dominance, and pharmaceutical composition for preventing or treating diseases26 Sep 2024US 2024/0315219 A1
- Anti-tau antibody and use of same30 Jun 2022US 2022/0204601 A1
- Mutated tau protein fragment and use thereof26 Aug 2021US 2021/0261633 A1
- Mutated tau protein fragment and use thereof31 Oct 2019US 2019/0330293 A1
Most cited
By later US patents
None of its patents has been cited by a later US patent yet.